Gallagher Neil insider trades
Gallagher Neil has filed 8 Form 4s with the SEC that we hold, for Syndax Pharmaceuticals Inc (SNDX) (President, Head of R&D), Foghorn Therapeutics Inc. (FHTX) (Director) and Zymeworks Inc. (ZYME) (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $71.6K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 4,618 shares of Syndax Pharmaceuticals Inc worth $71.6K, dated 2025-02-10. The first filing on our record is dated 2023-04-12 and the latest 2026-06-25.
Syndax Pharmaceuticals Inc (SNDX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-02-10 | S, sale reported on Form 4 | 4,618 | $71.6K | 2025-02-12 |
Foghorn Therapeutics Inc. (FHTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Zymeworks Inc. (ZYME)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1972849) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms